Literature DB >> 11526801

Etonogestrel implant (Implanon) for contraception.

.   

Abstract

Levonorgestrel 38 mg subdermal implant (Norplant), intended to provide contraception for 5 years, was withdrawn in the UK in 1999 due to unwanted effects (menstrual disturbances) and difficulties in removing the device. Since then, [symbol: see text]etonogestrel implant (Implanon-Organon), another progestogen--only subdermal contraceptive device, has become available in the UK. The manufacturer claims that etonogestrel implant provides contraception for up to 3 years and is easy to insert and remove. Here, we consider the place of etonogestrel implant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526801

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  1 in total

1.  Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.

Authors:  Peter Schnabel; Gabriele S Merki-Feld; Alice Malvy; Ingrid Duijkers; Ellen Mommers; Michiel W van den Heuvel
Journal:  Clin Drug Investig       Date:  2012-06-01       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.